Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Marie Roberson"'
Autor:
Tessa B. Long, David Wright, Edward A. Malone, Elizabeth Marie Roberson, Gowri G. Saraf, Irangi K. Egodapitiya
Publikováno v:
Technical Communication Quarterly. 20:443-480
Since the 1950s, technical communicators have been trying to predict future developments in technology, economics, pedagogy, and workplace roles. Prognosticators have included founders of the profession, academics, business leaders, and practitioners
Autor:
Marie Roberson, Christina Hodgkinson, Sara Goldman, Robert Currier, N. Neely Kazerouni, Fred Lorey
Publikováno v:
Prenatal Diagnosis. 30:981-987
Objective To evaluate the extent of fetal structural abnormalities, other than neural tube and abdominal wall defects (AWDs), identified by California's Prenatal Screening Program. Methods The Quad Marker Prenatal Screening records of 516,172 women w
Autor:
Marie Roberson, Wendy Y. Craig, Glenn E. Palomaki, Edward M. Kloza, Linda A Bradley, Cedric H.L. Shackleton, Josep Marcos, James E. Haddow
Publikováno v:
Prenatal Diagnosis. 29:771-780
Objective To document the performance of second trimester maternal urine and serum steroid measurements for detecting fetal steroid sulfatase deficiency (STSD). Methods We studied detection rate and false positive rate (DR, FPR) of analytes in matern
Autor:
Charles M. Strom, George C. Cunningham, Glenn E. Palomaki, George J. Knight, Marie Roberson, Raj Pandian, Jo Ellen Lee
Publikováno v:
Clinical Chemistry. 50:182-189
Background: Down syndrome screening is commonly performed in the US using maternal age and three or four second-trimester maternal serum markers that can identify up to 75% of affected pregnancies by offering diagnostic studies to 5% of women. Invasi
Autor:
Nilesh Dharajiya, Niloufar Neely Kazerouni, Iris Schrijver, Fred Lorey, Tina M. Cowan, Marie Roberson, Christina Hodgkinson
Publikováno v:
Molecular Genetics and Metabolism. 106:485-487
We report population findings from newborn screening for biotinidase deficiency in California, representing over 2,000,000 newborns. The incidence of profound deficiency was 1/73,629, higher than in other reported populations. Out of 28 patients with
Publikováno v:
Prenatal Diagnosis. 31:616-618
Autor:
Robert Currier, Fred Lorey, Niloufar Neely Kazerouni, Colin Hennigan, Sara Goldman, Linda Malm, Marie Roberson, Monica Flessel, Corinna Tempelis, Christina Hodgkinson
Publikováno v:
Prenatal diagnosis. 31(9)
Objective To evaluate the efficiency of California's quadruple-marker screening program and construct receiver-operating characteristic (ROC) curves. Methods This study included the screening records of 552 941 women during July 2007 to February 2009
Autor:
N Neely, Kazerouni, Robert J, Currier, Christina, Hodgkinson, Sara, Goldman, Fred, Lorey, Marie, Roberson
Publikováno v:
Prenatal diagnosis. 30(10)
To evaluate the extent of fetal structural abnormalities, other than neural tube and abdominal wall defects (AWDs), identified by California's Prenatal Screening Program.The Quad Marker Prenatal Screening records of 516,172 women were examined for sc
Autor:
Josep Marcos, Wendy Y. Craig, Cedric H.L. Shackleton, James E. Haddow, Marie Roberson, Glenn E. Palomaki
Publikováno v:
Prenatal diagnosis. 30(9)
Objective Estimate steroid sulfatase deficiency (STSD) prevalence among California's racial/ethnic groups using data from a previous study focused on prenatal detection of Smith-Lemli-Opitz syndrome (SLOS). SLOS and STSD both have low maternal serum
Autor:
Christina Hodgkinson, Bob Currier, N. Neely Kazerouni, Sylvia Smith, Linda Malm, Fred Lorey, Marie Roberson, Laura L. Jelliffe-Pawlowski, Lynn Walton-Haynes, Susan Riggle, Corinna Tempelis, Amber Davis
Publikováno v:
Obstetrics and gynecology. 114(1)
OBJECTIVE To examine screening performance of California's triple-marker screening program, using data from a statewide registry for chromosomal defects. METHODS This study included 752,686 women who received a screening risk and had an expected date